Connecting the Dots: Therapy-Induced Senescence and a Tumor-Suppressive Immune Microenvironment

BACKGROUND: Tumor cell senescence is a common outcome of anticancer therapy. Here we investigated how therapy-induced senescence (TIS) affects tumor-infiltrating leukocytes (TILs) and the efficacy of immunotherapy in melanoma. METHODS: Tumor senescence was induced by AURKA or CDK4/6 inhibitors (AURK...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Natl Cancer Inst
Autors principals: Vilgelm, Anna E., Johnson, C. Andrew, Prasad, Nripesh, Yang, Jinming, Chen, Sheau-Chiann, Ayers, Gregory D., Pawlikowski, Jeff S., Raman, Dayanidhi, Sosman, Jeffrey A., Kelley, Mark, Ecsedy, Jeffrey A., Shyr, Yu, Levy, Shawn E., Richmond, Ann
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4849355/
https://ncbi.nlm.nih.gov/pubmed/26719346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djv406
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars